On this episode we're very grateful to have interviewed PhD candidate Devin Abrahami, the first author of the paper "Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study" published in the March 2018 issue of the British Medical Journal. This paper from the group of Dr. Laurent Azoulay really made a lot of waves in the medical community, achieving an Altmetric score of 320 and still climbing and is a must-read.

Mcgill University Medical Podcast Series

Mcgill University Medical Podcast Series

Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

MAY 13, 201825 MIN
Mcgill University Medical Podcast Series

Episode 2 - Devin Abrahami - DPP-4 inhibitors and incidence of IBD among patients with DMII

MAY 13, 201825 MIN

Description

On this episode we're very grateful to have interviewed PhD candidate Devin Abrahami, the first author of the paper "Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study" published in the March 2018 issue of the British Medical Journal. This paper from the group of Dr. Laurent Azoulay really made a lot of waves in the medical community, achieving an Altmetric score of 320 and still climbing and is a must-read.